Tolerogenic dendritic cell therapy – causal treatment of autoimmune diseases
Background: Dendritic cells (DCs) are considered as primary carriers of antigenic (Ag) information in the human body. This information is later presented to Ag-specific T lymphocytes in various ways that can be either immunostimulating or immunosuppressive. The latter depends on the activation statu...
Main Authors: | Urban Švajger, Matjaž Jeras |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2013-01-01
|
Series: | Zdravniški Vestnik |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/733 |
Similar Items
-
The Role of Tolerogenic Dendritic Cell Therapy in Autoimmune Diseases
by: Maryam Shahidi, et al.
Published: (2018-03-01) -
Synergistic Effects of Interferon-γ and Vitamin D3 Signaling in Induction of ILT-3highPDL-1high Tolerogenic Dendritic Cells
by: Urban Švajger, et al.
Published: (2019-11-01) -
Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity
by: Laura Passeri, et al.
Published: (2021-08-01) -
TOLEROGENIC AND ACTIVATORY PLASMACYTOID DENDRITIC CELLS IN AUTOIMMUNITY
by: Leslie eGuery, et al.
Published: (2013-03-01) -
Immune tolerance
by: Matjaž Jeras, et al.
Published: (2011-12-01)